Ratner an international cadre of physicians, bioengineers and entrepreneurs working to revolutionize kidney failure treatment have developed the first-ever transplantable artificial kidney in an unprecedented invention that provides improved physiological outcomes for kidney disease patients. While promising to drive away with dialysis machines and implants. Millions of patients can be assured high quality of life because of this device. According to experts, the device will help those on a transplanted kidney get rid of lifelong immunosuppressant drugs that have a high risk of side effects. Also, kidney failure patients who have to go to the clinic every week for blood filters will also get relief.
The Kidney Project's winning artificial kidney is a smartphone-sized device that will revolutionize the treatment of kidney failure and that can be surgically implanted. This artificial kidney consists of two essential parts- the hemofilter and the bioreactor. The hemofilter removes waste products and blood toxins, while the bioreactor replicates kidney functions such as balancing blood electrolytes.
Each kidney has a mesh of about a million tiny filtering units, called nephrons. The blood entering the nephron passes through the glomerulus. The thin walls of the glomerulus enable waste, water and other small molecules to pass through while blocking larger molecules such as proteins and blood cells. From there, the filtered fluid flows into the renal tubules, where the balance of minerals, water, salt and glucose is calibrated and molecules needed for bodily functions are reabsorbed into the bloodstream. But many medical conditions can put a strain on the kidneys, including diabetes, obesity and high blood pressure.